Deep knowledge on
small-molecule drugs and
the 100,000 global patents
covering them

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

How are People Using DrugPatentWatch?

DrugPatentWatch Ultimate Plan Preview

Details for Patent: 6,150,366

« Back to Dashboard
Patent 6,150,366 protects GEODON and is included in two NDAs. There has been one Paragraph IV challenge on Geodon.

This patent has fifty-seven patent family members in forty-three countries.

Summary for Patent: 6,150,366

Title: Ziprasidone formulations
Abstract:Compositions comprising crystalline ziprasidone free base or crystalline ziprasidone hydrochloride particles having a mean particle size less than 85 .mu.m, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to treat psychoses such as schizophrenia.
Inventor(s): Arenson; Daniel R. (East Lyme, CT), Busch; Frank Robert (Gales Ferry, CT), Hausberger; Angela G. (East Lyme, CT), Rasadi; Bijan (Groton, CT)
Assignee: Pfizer Inc. (New York, NY)
Application Number:09/320,985
Patent Claim Types:
see list of patent claims
Composition; Formulation; Dosage form; Device; Use; Process;
Patent Metrics:
Source: PatentStat.com
Field: Not categorized
Back Citations: 12
Forward Citations: 0
Patent PDF download available with subscription

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-001Feb 5, 2001RXYes6,150,366<disabled>Y
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-002Feb 5, 2001RXNo6,150,366<disabled>Y
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-003Feb 5, 2001RXNo6,150,366<disabled>Y
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 6,150,366

Country Document Number Publication Date Supplementary Protection Certificate SPC Country SPC Expiration
South Korea20000006143Jan 25, 2000
Portugal965343Aug 29, 2003
Serbia49611Jun 04, 2007
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc